Tag

Hormone Therapy

All articles tagged with #hormone therapy

health1 hour ago•4 min saved

New Study Defines Menopause as a Sudden Physiological Cliff, Not a Gradual Decline

A large-scale study published in Nature Medicine argues that menopause is an abrupt, systemic physiological transition rather than a gradual decline. By analyzing 300 million lab tests from over one million women in the US and Israel, researchers found sudden shifts in bone, liver, kidney, and lipid systems at the final menstrual period. While hormone therapy mitigates these changes, experts debate whether the 'cliff' metaphor is scientifically accurate or overly alarming, noting that hormonal changes begin over a decade before menopause.

via ScienceAlert|

#bone-health #endocrinology #health

health6 hours ago•44 min saved

Study Finds Menopause Causes Abrupt Physiological Shifts, Not Gradual Decline

A new study published in Nature Medicine reveals that menopause triggers a sudden, systemic 'cliff' in physiological markers rather than a gradual decline. By analyzing 300 million lab tests from over one million women, researchers identified abrupt changes in bone, liver, kidney, and lipid systems at the final menstrual period. The findings suggest that hormonal dysregulation begins more than a decade earlier than previously thought, and that hormone therapy significantly mitigates these shifts.

via Nature|

#endocrinology #health #hormone-therapy

health12 days ago•58 min saved

Perimenopause Awareness Month Sparks Community, Medical Debate, and New Care Models

September’s Perimenopause Awareness Month has highlighted a growing movement of women seeking community and medical solutions for symptoms like brain fog and sleep disruption. While some find support through informal groups and new literature, medical experts emphasize that symptoms are treatable but require careful evaluation. The conversation is shifting from silence to active management, though perspectives on treatment vary from community bonding to clinical interventions.

via BuzzFeed|

#community-support #health #hormone-therapy

health-and-wellness13 days ago•3 min saved

Suburban Moms Build Perimenopause Support Network as Awareness Month Highlights Untreated Symptoms

Suburban mothers are forming informal support groups to address perimenopause symptoms, a topic historically stigmatized. While medical experts emphasize that symptoms like brain fog and joint pain are treatable, many women still face misdiagnosis and isolation. New community initiatives and literature aim to normalize these conversations.

via NBC 5 Chicago|

#community-support #health-and-wellness #hormone-therapy

health13 days ago•2 min saved

Danish Study: Oral Menopause Hormone Therapy Raises Clot Risk, While Transdermal Shows Better Safety Profile

A large Danish study finds that oral menopausal hormone therapy (MHT) increases the risk of blood clots, stroke, and heart attack, with risks varying by dose and duration. Transdermal MHT shows a significantly better safety profile, with no overall increase in thrombotic events except for a specific combined cyclic regimen. The findings suggest that the route of administration is a critical factor in minimizing cardiovascular risks for women using MHT.

via Medscape|

#bmj #cardiovascular-health #health

health14 days ago•5 min saved

Microdosing GLP-1s in Perimenopause: Emerging Science, Risks, and Gaps in Evidence

Microdosing GLP-1 receptor agonists like semaglutide and tirzepatide at doses significantly lower than standard prescriptions is gaining traction among clinicians treating perimenopausal women. This approach aims to address metabolic shifts caused by declining estrogen, which naturally reduces the body's own GLP-1 signaling. While low doses may improve insulin sensitivity and reduce gastrointestinal side effects, the practice remains off-label with limited rigorous scientific support. Experts emphasize that while metabolic benefits may precede weight loss, the lack of standardized guidelines and potential risks, such as muscle loss, necessitate careful, individualized medical supervision.

via MindBodyGreen|

#glp-1-agonists #health #hormone-therapy

health16 days ago•71 min saved

A five-year-old girl with precocious puberty may freeze her eggs to preserve future fertility

A five-year-old girl in London diagnosed with central precocious puberty at 10 months old is being considered for egg freezing by her mother to preserve future fertility options. The child currently receives monthly hormone-blocking injections to suppress puberty, a treatment that may continue until age 11 or 12. While the condition has no known cause in many cases, it can impact adult height and has already led to bullying at school due to hormone-related skin changes. Early medical intervention was critical in identifying and managing the condition.

via Yahoo|

#egg-freezing #fertility-preservation #health

health16 days ago•5 min saved

New '10-Year Rule' Helps Distinguish Menopause Brain Fog from Dementia

A UCLA neurologist proposes a self-assessment benchmark to help women differentiate between menopause-related cognitive changes and early dementia, emphasizing that subjective decline often precedes clinical detection.

via foxnews.com|

#brain-fog #cognitive-health #health

health17 days ago•6 min saved

London mother considers egg freezing for daughter diagnosed with precocious puberty at 10 months

A five-year-old girl in London, Sienna, was diagnosed with central precocious puberty at 10 months old after a health visitor noticed enlarged breast tissue. Her mother, Sophie Dumas, is considering freezing Sienna’s eggs to preserve future fertility options. Sienna currently receives monthly hormone-blocking injections to suppress puberty, a treatment she may continue until age 11 or 12. The condition, which has no known cause in many cases, can affect adult height and has already led to bullying at school due to hormone-related skin changes. Dumas emphasizes the importance of early medical intervention, noting that without the health visitor’s observation, Sienna might not have received treatment so early.

via New York Post|

#child-health #egg-freezing #health

health20 days ago•2 min saved

New Research and FDA Changes Reshape Perimenopause Care

Recent shifts in medical understanding and FDA policy are increasing awareness of perimenopause. Researchers at Penn Medicine are investigating links between sleep irregularity, mood disorders, and cognitive symptoms, while new data highlights disparities in hormone therapy access.

via Penn Today|

#brain-fog #health #hormone-therapy

health20 days ago•7 min saved

Menopausal Women Turn to Unregulated Peptides as DIY Hormone Therapy

A growing number of women are bypassing traditional medical channels to use experimental, unapproved peptides for managing menopause and perimenopause symptoms. Driven by social media influencers and a lack of effective conventional treatments, these individuals often self-administer injectable compounds like retatrutide and BPC-157. While many report significant improvements in energy, mood, and weight, the practice carries substantial risks, including incorrect dosing, adverse physical reactions, and exposure to counterfeit products. Medical experts warn that the lack of regulation and clinical oversight makes this a dangerous 'gray market' trend.

via New York Post|

#diy-medicine #gray-market #health

health26 days ago•9 min saved

Veoza offers non-hormonal relief for menopause hot flashes, but cannot replace HRT for broader symptoms

Veoza (fezolinetant) is a non-hormonal drug approved in 2024 to treat menopausal hot flushes and night sweats by blocking brain signals that regulate temperature. Unlike hormone replacement therapy (HRT), it does not replace estrogen, meaning it cannot treat other menopause symptoms like vaginal dryness or bone density loss. Clinical trials show it reduces daily hot flushes from 10-12 to 4-5, offering partial relief for women who cannot take HRT. While effective for vasomotor symptoms, it carries risks of liver injury and does not address the full spectrum of menopause-related health issues.

via The Conversation|

#health #hormone-therapy #menopause

health1 month ago•4 min saved

Control LDL Before Hormone Therapy to Lower Heart Risk

A Medscape commentary on the WHI trials shows baseline LDL cholesterol strongly influences coronary risk during menopausal hormone therapy. Among women with LDL <130 mg/dL there was no significant CHD risk increase with estrogen therapy, while those with LDL ≥190 mg/dL had markedly higher risk with estrogen plus progestin; HDL levels and HDL ratio also affected risk in the CEE-alone trial, whereas blood pressure and glucose were less influential. The piece recommends assessing and controlling lipids before starting systemic hormone therapy (using AHA/ACC 2026 lipid guidelines and PREVENT equations) to mitigate risk, notes that normal or treated lipid levels may negate CHD risk elevations, and suggests further research on other hormone therapies. Lipid assessment and control are advised for all women to reduce cardiovascular risk.

via Medscape|

#cardiovascular-risk #health #hormone-therapy

medicine1 month ago•4 min saved

Early Menopause Hormone Therapy Linked to Lower Cardiovascular Risk in Women with Hot Flashes

A SWAN-cohort analysis found that starting menopausal hormone therapy (MHT) in perimenopause or early postmenopause for women with vasomotor symptoms is associated with a lower risk of cardiovascular disease (HR 0.78 overall; 0.73 if begun within 10 years of menopause). The benefit appears strongest among Black women (HR 0.51). These findings are observational and not a recommendation to use MHT for CVD prevention; randomized trials are still needed. The study included 2,737 women, with about 9–12 years of follow-up and 224 cardiovascular events.

via Medscape|

#cardiovascular-risk #hormone-therapy #medicine

technology1 month ago•24 min saved

The Perimenopause Startup Boom: Telehealth, Hormones, and a New Health Frontier

WIRED examines a rapid, venture-backed surge in hormone therapy for perimenopause driven by telehealth platforms (Midi, Winona, Alloy, Evernow) and policy shifts after FDA warnings were lifted, fueling broad marketing of a wide range of symptoms as solvable by hormones. The piece juxtaposes patient‑level relief with warnings about overdiagnosis, safety risks, and supply constraints, arguing the trend reflects a broader move toward platform‑based, privatized women’s health care.

via WIRED|

#hormone-therapy #perimenopause #startups